Absence of a 'smoker's paradox' in field triaged ST-elevation myocardial infarction patients undergoing percutaneous coronary intervention

Cardiovascular Revascularization Medicine

Volumn 14, Issue 4, 2013, Pages 213-217

  Allahwala, Usaid K ^a   Murphy, John C ^a   Nelson, Gregory I C ^a   Bhindi, Ravinay ^a  

^a ROYAL NORTH SHORE HOSPITAL   (Australia)

Author keywords

Early Field Triage; Smoker's paradox; ST Elevation Myocardial Infarction

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD CLOT LYSIS; CARDIOVASCULAR MORTALITY; CLINICAL INDICATOR; COHORT ANALYSIS; COMORBIDITY; EMERGENCY HEALTH SERVICE; FEMALE; HEART ARREST; HEART DISEASE; HUMAN; KIDNEY DYSFUNCTION; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SMOKER PARADOX; SMOKING; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;

EARLY FIELD TRIAGE; SMOKER'S PARADOX; ST ELEVATION MYOCARDIAL INFARCTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HEMORRHAGE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PULMONARY EDEMA; RETROSPECTIVE STUDIES; SMOKING; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84881372068     PISSN: 15538389     EISSN: 18780938     Source Type: Journal    
DOI: 10.1016/j.carrev.2013.06.002     Document Type: Article

References (42)

1. Barbash G.I., Reiner J., White H.D., Wilcox R.G., Armstrong P.W., Sadowski Z., et al. Evaluation of paradoxic beneficial effects of smoking in patients receiving thrombolytic therapy for acute myocardial infarction: mechanism of the "smoker's paradox" from the GUSTO-I trial, with angiographic insights. Global Utilization of Streptokinase and Tissue-Plasminogen Activator for Occluded Coronary Arteries. J Am Coll Cardiol 1995, 26(5):1222-1229.
2. Helmers C. Short and long-term prognostic indices in acute myocardial infarction. A study of 606 patients initially treated in a coronary care unit. Acta Med Scand Suppl 1973, 555:7-26.
3. Kelly T.L., Gilpin E., Ahnve S., Henning H., Ross J. Smoking status at the time of acute myocardial infarction and subsequent prognosis. Am Heart J 1985, 110(3):535-541.
4. Barbash G.I., White H.D., Modan M., Diaz R., Hampton J.R., Heikkila J., et al. Significance of smoking in patients receiving thrombolytic therapy for acute myocardial infarction. Experience gleaned from the International Tissue Plasminogen Activator/Streptokinase Mortality Trial. Circulation 1993, 87(1):53-58.
5. Jaatun HJ, Sutradhar SC, Dickstein K, OPTIMAAL Study Group. Comparison of mortality rates after acute myocardial infarction in smokers versus nonsmokers. Am J Cardiol 2004;94(5):632-636, A639.
6. Jorgensen, Kober L., Ottesen M.M., Torp-Pedersen C., Videbaek J., Kjoller E. The prognostic importance of smoking status at the time of acute myocardial infarction in 6676 patients TRACE Study Group. J Cardiovasc Risk 1999, 6(1):23-27.
7. Weisz G., Cox D.A., Garcia E., Tcheng J.E., Griffin J.J., Guagliumi G., et al. Impact of smoking status on outcomes of primary coronary intervention for acute myocardial infarction-the smoker's paradox revisited. Am Heart J 2005, 150(2):358-364.
8. Himbert D., Klutman M., Steg G., White K., Gulba D.C. Cigarette smoking and acute coronary syndromes: a multinational observational study. Int J Cardiol 2005, 100(1):109-117.
9. Verouden N.J., Haeck J.D., Kuijt W.J., Meuwissen M., Koch K.T., Henriques J.P., et al. Clinical and angiographic predictors of ST-segment recovery after primary percutaneous coronary intervention. Am J Cardiol 2010, 105(12):1692-1697.
10. Sukiennik A., Kozinski M., Debska-Kozinska K., Kubica A., Grabczewska Z., Kubica J. Smokers versus non-smokers undergoing percutaneous transluminal coronary angioplasty: the impact of clinical and procedural characteristics on in-hospital mortality. Cardiol J 2007, 14(5):482-492.
11. Zahger D., Cercek B., Cannon C.P., Jordan M., Davis V., Braunwald E., et al. How do smokers differ from nonsmokers in their response to thrombolysis? (the TIMI-4 trial). Am J Cardiol 1995, 75(4):232-236.
12. Lundergan C.F., Reiner J.S., McCarthy W.F., Coyne K.S., Califf R.M., Ross A.M. Clinical predictors of early infarct-related artery patency following thrombolytic therapy: importance of body weight, smoking history, infarct-related artery and choice of thrombolytic regimen: the GUSTO-I experience. Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries. J Am Coll Cardiol 1998, 32(3):641-647.
13. de Chillou C., Riff P., Sadoul N., Ethevenot G., Feldmann L., Isaaz K., et al. Influence of cigarette smoking on rate of reopening of the infarct-related coronary artery after myocardial infarction: a multivariate analysis. J Am Coll Cardiol 1996, 27(7):1662-1668.
14. Lee K.L., Woodlief L.H., Topol E.J., Weaver W.D., Betriu A., Col J., et al. Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction. Results from an international trial of 41,021 patients. GUSTO-I Investigators. Circulation 1995, 91(6):1659-1668.
15. Barbash G.I., White H.D., Modan M., Diaz R., Hampton J.R., Heikkila J., et al. Acute myocardial infarction in the young-the role of smoking. The Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality Trial. Eur Heart J 1995, 16(3):313-316.
16. Maggioni A.P., Piantadosi F., Tognoni G., Santoro E., Franzosi M.G. Smoking is not a protective factor for patients with acute myocardial infarction: the viewpoint of the GISSI-2 Study. G Ital Cardiol 1998, 28(9):970-978.
17. Svilaas T., Vlaar P.J., van der Horst I.C., Diercks G.F., de Smet B.J., van den Heuvel A.F., et al. Thrombus aspiration during primary percutaneous coronary intervention. N Engl J Med 2008, 358(6):557-567.
18. Gibson C.M., Pride Y.B., Frederick P.D., Pollack C.V., Canto J.G., Tiefenbrunn A.J., et al. Trends in reperfusion strategies, door-to-needle and door-to-balloon times, and in-hospital mortality among patients with ST-segment elevation myocardial infarction enrolled in the National Registry of Myocardial Infarction from 1990 to 2006. Am Heart J 2008, 156(6):1035-1044.
19. Carstensen S., Nelson G.C., Hansen P.S., Macken L., Irons S., Flynn M., et al. Field triage to primary angioplasty combined with emergency department bypass reduces treatment delays and is associated with improved outcome. Eur Heart J 2007, 28(19):2313-2319.
20. Pedersen S.H., Galatius S., Hansen P.R., Mogelvang R., Abildstrom S.Z., Sorensen R., et al. Field triage reduces treatment delay and improves long-term clinical outcome in patients with acute ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention. J Am Coll Cardiol 2009, 54(24):2296-2302.
21. McNamara R.L., Wang Y., Herrin J., Curtis J.P., Bradley E.H., Magid D.J., et al. Effect of door-to-balloon time on mortality in patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol 2006, 47(11):2180-2186.
22. Brodie B.R., Gersh B.J., Stuckey T., Witzenbichler B., Guagliumi G., Peruga J.Z., et al. When is door-to-balloon time critical? Analysis from the HORIZONS-AMI (Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction) and CADILLAC (Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications) trials. J Am Coll Cardiol 2010, 56(5):407-413.
23. Postma S., Dambrink J.H., de Boer M.J., Gosselink A.T., Eggink G.J., van de Wetering H., et al. rehospital triage in the ambulance reduces infarct size and improves clinical outcome. Am Heart J 2011, 161(2):276-282.
24. Rentrop K.P., Cohen M., Blanke H., Phillips R.A. Changes in collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects. J Am Coll Cardiol 1985, 5(3):587-592.
25. Smith G.L., Masoudi F.A., Shlipak M.G., Krumholz H.M., Parikh C.R. Renal impairment predicts long-term mortality risk after acute myocardial infarction. J Am Soc Nephrol 2008, 19(1):141-150.
26. Newby L.K., Bhapkar M.V., White H.D., Topol E.J., Dougherty F.C., Harrington R.A., et al. Predictors of 90-day outcome in patients stabilized after acute coronary syndromes. Eur Heart J 2003, 24(2):172-181.
27. Zhang Z., Fang J., Gillespie C., Wang G., Hong Y., Yoon P.W. Age-specific gender differences in in-hospital mortality by type of acute myocardial infarction. Am J Cardiol 2012, 109(8):1097-1103.
28. Akhter N., Milford-Beland S., Roe M.T., Piana R.N., Kao J., Shroff A. Gender differences among patients with acute coronary syndromes undergoing percutaneous coronary intervention in the American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR). Am Heart J 2009, 157(1):141-148.
29. Horne R., James D., Petrie K., Weinman J., Vincent R. Patients' interpretation of symptoms as a cause of delay in reaching hospital during acute myocardial infarction. Heart 2000, 83(4):388-393.
30. Dracup K., Moser D.K., Eisenberg M., Meischke H., Alonzo A.A., Braslow A. Causes of delay in seeking treatment for heart attack symptoms. Soc Sci Med 1995, 40(3):379-392.
31. Moser D.K., Kimble L.P., Alberts M.J., Alonzo A., Croft J.B., Dracup K., et al. Reducing delay in seeking treatment by patients with acute coronary syndrome and stroke: a scientific statement from the American Heart Association Council on cardiovascular nursing and stroke council. Circulation 2006, 114(2):168-182.
32. Meier P., Hemingway H., Lansky A.J., Knapp G., Pitt B., Seiler C. The impact of the coronary collateral circulation on mortality: a meta-analysis. Eur Heart J 2012, 33(5):614-621.
33. Heeschen C., Weis M., Cooke J.P. Nicotine promotes arteriogenesis. J Am Coll Cardiol 2003, 41(3):489-496.
34. Burke A., Fitzgerald G.A. Oxidative stress and smoking-induced vascular injury. Prog Cardiovasc Dis 2003, 46(1):79-90.
35. Koerselman J., de Jaegere P.P., Verhaar M.C., Grobbee D.E., van der Graaf Y. Coronary collateral circulation: the effects of smoking and alcohol. Atherosclerosis 2007, 191(1):191-198.
36. Kornowski R. Collateral formation and clinical variables in obstructive coronary artery disease: the influence of hypercholesterolemia and diabetes mellitus. Coron Artery Dis 2003, 14(1):61-64.
37. Cohen M., Sherman W., Rentrop K.P., Gorlin R. Determinants of collateral filling observed during sudden controlled coronary artery occlusion in human subjects. J Am Coll Cardiol 1989, 13(2):297-303.
38. Grines C.L., Topol E.J., O'Neill W.W., George B.S., Kereiakes D., Phillips H.R., et al. Effect of cigarette smoking on outcome after thrombolytic therapy for myocardial infarction. Circulation 1995, 91(2):298-303.
39. Angeja B.G., Kermgard S., Chen M.S., McKay M., Murphy S.A., Antman E.M., et al. The smoker's paradox: insights from the angiographic substudies of the TIMI trials. J Thromb Thrombolysis 2002, 13(3):133-139.
40. Burke A.P., Farb A., Malcom G.T., Liang Y.H., Smialek J., Virmani R. Coronary risk factors and plaque morphology in men with coronary disease who died suddenly. N Engl J Med 1997, 336(18):1276-1282.
41. Purcell I.F., Newall N., Farrer M. Lower cardiac mortality in smokers following thrombolysis for acute myocardial infarction may be related to more effective fibrinolysis. QJM 1999, 92(6):327-333.
42. Sonke G.S., Stewart A.W., Beaglehole R., Jackson R., White H.D. Comparison of case fatality in smokers and non-smokers after acute cardiac event. BMJ 1997, 315(7114):992-993.